Page last updated: 2024-11-05

flavaspidic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

flavaspidic acid: isolated from rhizomes of male fern; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8237
CHEMBL ID291819
SCHEMBL ID1785484
MeSH IDM0046264

Synonyms (33)

Synonym
nsc 115497
brn 2068481
2,5-cyclohexadien-1-one, 3,5-dihydroxy-4,4-dimethyl-2-(1-oxobutyl)-6-((2,4,6-trihydroxy-3-methyl-5-(1-oxobutyl)phenyl)methyl)-
flavaspidsaeure [german]
butyrophenone, 3'-((5-butyryl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl)-2',4',6'-trihydroxy-5'-methyl-
3'-((5-butyryl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl)-5'-methylphloro butyrophenone
wln: l6v dhj bv3 cq d1 d1 eq f1r bq dq fq c1 ev3
nsc-115497
flavaspidic acid bb
butyrophenone,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl]-2',4',6'-trihydroxy-5'-methyl-
nsc115497
glavaspidic acid
2, 3,5-dihydroxy-4,4-dimethyl-2-(1-oxobutyl)-6-[[2,4,6-trihydroxy-3-methyl-5-(1-oxobutyl)phenyl]methyl]-
toxifren
flavaspidic acid
flavaspidsaeure
114-42-1
2,5-cyclohexadien-1-one, 3,5-dihydroxy-4,4-dimethyl-2-(1-oxobutyl)-6-[[2,4,6-trihydroxy-3-methyl-5-(1-oxobutyl)phenyl]methyl]-
2-butanoyl-6-[(3-butanoyl-2,4,6-trihydroxy-5-methyl-phenyl)methyl]-3,5-dihydroxy-4,4-dimethyl-cyclohexa-2,5-dien-1-one
NCI60_000345
CHEMBL291819
2-butanoyl-4-[(3-butanoyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-3,5-dihydroxy-6,6-dimethylcyclohexa-2,4-dien-1-one
4-08-00-03748 (beilstein handbook reference)
unii-7hfr949xw9
7hfr949xw9 ,
flavaspidic acid .alpha.-form [mi]
flavaspidic acid .beta.-form [mi]
flavaspidic acid [mi]
3,5-dihydroxy-4,4-dimethyl-2-(1-oxobutyl)-6-((2,4,6-trihydroxy-3-methyl-5-(1-oxobutyl)phenyl)methyl)-2,5-cyclohexadien-1-one
phlorobutyrophenone, 3'-((5-butyryl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl)-5'-methyl-
SCHEMBL1785484
Q5458045
DTXSID90878659

Research Excerpts

Overview

Flavaspidic acid AB (FA-AB) is a compound derived from Dryopteris crassirhizoma, a traditional antiviral Chinese medicine.

ExcerptReferenceRelevance
"Flavaspidic acid AB (FA-AB) is a compound derived from Dryopteris crassirhizoma, a traditional antiviral Chinese medicine."( Inhibition of porcine reproductive and respiratory syndrome virus replication by flavaspidic acid AB.
Cao, L; Feng, WH; Gao, L; Liu, J; Si, J; Sun, Y; Yang, Q, 2013
)
1.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (NEW YORK-5 ISOLATE)IC50 (µMol)26.00000.00020.10421.7000AID1795255
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Protease Human immunodeficiency virus 1ID5026.00000.00140.85491.7000AID162539
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID162539Evaluated for the inhibition of HIV-1 Protease.1996Journal of medicinal chemistry, May-10, Volume: 39, Issue:10
Discovery of novel, non-peptide HIV-1 protease inhibitors by pharmacophore searching.
AID1795255Protease Inhibition Assay from Article 10.1021/jm950874+: \\Discovery of novel, non-peptide HIV-1 protease inhibitors by pharmacophore searching.\\1996Journal of medicinal chemistry, May-10, Volume: 39, Issue:10
Discovery of novel, non-peptide HIV-1 protease inhibitors by pharmacophore searching.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (50.00)18.7374
1990's2 (12.50)18.2507
2000's2 (12.50)29.6817
2010's1 (6.25)24.3611
2020's3 (18.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.51 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]